These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 7898917

  • 21. Differential expression of the transcription factor NF-kappaB during human mononuclear phagocyte differentiation to macrophages and dendritic cells.
    Ammon C, Mondal K, Andreesen R, Krause SW.
    Biochem Biophys Res Commun; 2000 Feb 05; 268(1):99-105. PubMed ID: 10652220
    [Abstract] [Full Text] [Related]

  • 22. Induction of nuclear factor-kappa B during primary B cell differentiation.
    Kistler B, Rolink A, Marienfeld R, Neumann M, Wirth T.
    J Immunol; 1998 Mar 01; 160(5):2308-17. PubMed ID: 9498771
    [Abstract] [Full Text] [Related]

  • 23. In vitro selection of optimal RelB/p52 DNA-binding motifs.
    Britanova LV, Makeev VJ, Kuprash DV.
    Biochem Biophys Res Commun; 2008 Jan 18; 365(3):583-8. PubMed ID: 17996728
    [Abstract] [Full Text] [Related]

  • 24. Mutant envelope residues confer a transactivation function onto N-terminal sequences of the v-Rel oncoprotein.
    Epinat JC, Kazandjian D, Harkness DD, Petros S, Dave J, White DW, Gilmore TD.
    Oncogene; 2000 Feb 03; 19(5):599-607. PubMed ID: 10698504
    [Abstract] [Full Text] [Related]

  • 25. The role of Rel/NF-kappa B proteins in viral oncogenesis and the regulation of viral transcription.
    Mosialos G.
    Semin Cancer Biol; 1997 Apr 03; 8(2):121-9. PubMed ID: 9299590
    [Abstract] [Full Text] [Related]

  • 26. Rel/NF-kappa B transcription factors and I kappa B inhibitors: evolution from a unique common ancestor.
    Huguet C, Crepieux P, Laudet V.
    Oncogene; 1997 Dec 11; 15(24):2965-74. PubMed ID: 9416840
    [Abstract] [Full Text] [Related]

  • 27. Characterization of CD40 signaling determinants regulating nuclear factor-kappa B activation in B lymphocytes.
    Hsing Y, Hostager BS, Bishop GA.
    J Immunol; 1997 Nov 15; 159(10):4898-906. PubMed ID: 9366415
    [Abstract] [Full Text] [Related]

  • 28. NF-kappa B2 p100 is a pro-apoptotic protein with anti-oncogenic function.
    Wang Y, Cui H, Schroering A, Ding JL, Lane WS, McGill G, Fisher DE, Ding HF.
    Nat Cell Biol; 2002 Nov 15; 4(11):888-93. PubMed ID: 12389034
    [Abstract] [Full Text] [Related]

  • 29. RelB, a member of the Rel/NF-kappa B family of transcription factors.
    Ryseck RP, Weih F, Carrasco D, Bravo R.
    Braz J Med Biol Res; 1996 Jul 15; 29(7):895-903. PubMed ID: 9070378
    [Abstract] [Full Text] [Related]

  • 30. CD40 regulates the processing of NF-kappaB2 p100 to p52.
    Coope HJ, Atkinson PG, Huhse B, Belich M, Janzen J, Holman MJ, Klaus GG, Johnston LH, Ley SC.
    EMBO J; 2002 Oct 15; 21(20):5375-85. PubMed ID: 12374738
    [Abstract] [Full Text] [Related]

  • 31. Stabilization of RelB requires multidomain interactions with p100/p52.
    Fusco AJ, Savinova OV, Talwar R, Kearns JD, Hoffmann A, Ghosh G.
    J Biol Chem; 2008 May 02; 283(18):12324-32. PubMed ID: 18321863
    [Abstract] [Full Text] [Related]

  • 32. Differential interactions of Rel-NF-kappa B complexes with I kappa B alpha determine pools of constitutive and inducible NF-kappa B activity.
    Dobrzanski P, Ryseck RP, Bravo R.
    EMBO J; 1994 Oct 03; 13(19):4608-16. PubMed ID: 7925301
    [Abstract] [Full Text] [Related]

  • 33. NF-kappa B p100 (Lyt-10) is a component of H2TF1 and can function as an I kappa B-like molecule.
    Scheinman RI, Beg AA, Baldwin AS.
    Mol Cell Biol; 1993 Oct 03; 13(10):6089-101. PubMed ID: 8413211
    [Abstract] [Full Text] [Related]

  • 34. Constitutive and inducible Rel/NF-kappa B activities in mouse thymus and spleen.
    Weih F, Carrasco D, Bravo R.
    Oncogene; 1994 Nov 03; 9(11):3289-97. PubMed ID: 7936653
    [Abstract] [Full Text] [Related]

  • 35. Gastric hyperplasia and increased proliferative responses of lymphocytes in mice lacking the COOH-terminal ankyrin domain of NF-kappaB2.
    Ishikawa H, Carrasco D, Claudio E, Ryseck RP, Bravo R.
    J Exp Med; 1997 Oct 06; 186(7):999-1014. PubMed ID: 9314550
    [Abstract] [Full Text] [Related]

  • 36. The NF-κB subunit RelB controls p100 processing by competing with the kinases NIK and IKK1 for binding to p100.
    Fusco AJ, Mazumder A, Wang VY, Tao Z, Ware C, Ghosh G.
    Sci Signal; 2016 Sep 27; 9(447):ra96. PubMed ID: 27678221
    [Abstract] [Full Text] [Related]

  • 37. Overexpression of RelB in transgenic mice does not affect I kappa B alpha levels: differential regulation of RelA and RelB by the inhibitor protein.
    Weih F, Lira SA, Bravo R.
    Oncogene; 1996 Jan 18; 12(2):445-9. PubMed ID: 8570223
    [Abstract] [Full Text] [Related]

  • 38. Critical role of RelB serine 368 for dimerization and p100 stabilization.
    Maier HJ, Marienfeld R, Wirth T, Baumann B.
    J Biol Chem; 2003 Oct 03; 278(40):39242-50. PubMed ID: 12874295
    [Abstract] [Full Text] [Related]

  • 39. Differential regulation of NF-kappaB2(p100) processing and control by amino-terminal sequences.
    Betts JC, Nabel GJ.
    Mol Cell Biol; 1996 Nov 03; 16(11):6363-71. PubMed ID: 8887665
    [Abstract] [Full Text] [Related]

  • 40. Regulation of immune responses by NF-kappa B/Rel transcription factor.
    Sha WC.
    J Exp Med; 1998 Jan 19; 187(2):143-6. PubMed ID: 9432972
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.